Skip to main content

Table 1 CD13 and EPCR positive (+) microparticles in response to recombinant human activated protein C (rhAPC)

From: The clinical and functional relevance of microparticles induced by activated protein C treatment in sepsis

 

CD13+ (x 106/ml)

EPCR+ (x 106/ml)

Patient No.

Pre-rhAPC

During rhAPC

Pre-rhAPC

During rhAPC

1

4.88

8.21

2.8

5.16

2

7.77

41.33

5.8

27.55

3

6.27

24.38

3.37

16.53

4

8.56

12.42

6.62

11.42

5

1.92

71.30

1.06

54.41

6

21.83

35.92

13.1

33.04

Median

7.02

30.15*

4.59

22.04*

  1. During rhAPC indicates day 1 of treatment. *= p ≤ 0.025 comparing pre- vs. during treatment effects using a Mann-Whitney U test with Bonferroni correction.